Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Johnson & Johnson
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Infobox company | name = Johnson & Johnson | logo = Johnson and Johnson Logo.svg | logo_size = 260px | image = JohnsonJohnson HQ building.jpg | image_size = 250px | image_caption = Headquarters at One [[Johnson and Johnson Plaza]] in [[New Brunswick, New Jersey|New Brunswick]], [[New Jersey]] | type = [[Public company|Public]] | traded_as = {{Unbulleted list | {{New York Stock Exchange|JNJ}} | [[Dow Jones Industrial Average|DJIA]] component | [[S&P 100]] component | [[S&P 500]] component }} | ISIN = {{ISIN|sl=n|pl=y|US4781601046}} | industry = {{Unbulleted list | [[Pharmaceutical industry|Pharmaceutical]] | [[Medical Technology]] }} | founded = {{Start date and age|1886|1}} in [[New Brunswick, New Jersey]], United States | founders = {{Unbulleted list | [[Robert Wood Johnson I]] | [[James Wood Johnson]] | [[Edward Mead Johnson]] }} | location = [[Johnson and Johnson Plaza]] | location_city = [[New Brunswick, New Jersey]] | location_country = [[United States|U.S.]]<br/>{{Coord|40|29|55|N|74|26|37|W|format=dms|type:landmark_region:US-NJ|display=title,inline}} | area_served = Worldwide | key_people = {{Unbulleted list | [[Joaquin Duato]] |([[Chairman]] & [[Chief executive officer|CEO]]) }} | products = [[List of Johnson & Johnson products and services]] | revenue = {{increase}} {{US$|94.94 billion|link=yes}} (2022) | operating_income = {{decrease}} {{US$|21.73 billion}} (2022) | net_income = {{decrease}} {{US$|17.94 billion}} (2022) | assets = {{increase}} {{US$|187.4 billion}} (2022) | equity = {{increase}} {{US$|76.80 billion}} (2022) | num_employees = {{increase}} 155,800 (January 2023) | subsid = {{Unbulleted list | [[Abiomed]] | [[Acclarent]] | [[Actelion]] | [[Cilag]] | [[DePuy Synthes]] | [[Ethicon]] | [[Janssen Biotech]] | [[Janssen Pharmaceuticals]] | [[Janssen Vaccines]] | [[Johnson & Johnson Vision]] | [[Mentor (company)|Mentor]] | [[Synthes]] }} | website = {{URL|jnj.com}} | footnotes = <ref name=10K-2022>{{cite web |url=https://www.sec.gov/ix?doc=/Archives/edgar/data/200406/000020040623000016/jnj-20230101.htm |title=Johnson and Johnson 2022 Annual Report (Form 10-K) |date=February 16, 2023 |publisher=[[U.S. Securities and Exchange Commission]]}}</ref> }} Johnson & Johnson (J&J) is a multinational corporation hailing from the United States, specializing in pharmaceuticals and medical technologies. Its headquarters are situated in New Brunswick, New Jersey, and it's publicly traded on the New York Stock Exchange. The company's common stock is part of the Dow Jones Industrial Average, and it holds the 40th position on the 2023 Fortune 500 list, showcasing the largest corporations in the United States. Johnson & Johnson boasts a global workforce of around 130,000 employees, with Joaquin Duato currently serving as the chairman and chief executive officer. Founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, the company initially focused on selling pre-packaged sterile surgical dressings. In 2023, Johnson & Johnson underwent a significant transformation, spinning off its consumer healthcare business group into a new publicly traded entity called Kenvue. The company's exclusive dedication now lies in the development and manufacture of pharmaceutical prescription drugs and medical device technologies. It stands as one of the world's most valuable firms and is among the select few U.S.-based companies with a coveted AAA credit rating. Headquartered in New Brunswick, New Jersey, with its consumer division located in Skillman, New Jersey, Johnson & Johnson's vast corporate structure encompasses approximately 250 subsidiary companies operating in 60 countries, with products distributed in over 175 nations. In the calendar year 2021, the company achieved worldwide sales totaling $93.8 billion. In November 2021, Johnson & Johnson made a strategic announcement of its intention to split into two publicly traded companies: one with a primary focus on consumer products and the other dedicated to pharmaceuticals and medical technologies.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)